(Q42986490)

12 November 2017

title

Severe hepatitis C infection in a renal transplant recipient following hepatitis C genotype mismatch transplant (English)

1 reference

12 November 2017

1 reference

Thomas Schussler

1

1 reference

12 November 2017

Catherine Staffeld-Coit

series ordinal

2

1 reference

12 November 2017

James Eason

series ordinal

3

1 reference

12 November 2017

Satheesh Nair

series ordinal

4

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

American Journal of Transplantation

12 November 2017

published in

1 reference

12 November 2017

volume

4

1 reference

12 November 2017

issue

8

1 reference

12 November 2017

page(s)

1375-1378

1 reference

A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

Hepatitis C infection and post-transplantation liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

Impact of immunosuppressive therapy on recurrence of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00504.X

10.1111/J.1600-6143.2004.00504.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference